Scope
Acute heart-failure and cardiogenic pulmonary-oedema recognition using the national NHFA/CSANZ heart-failure guideline and the exact Queensland PCCM acute pulmonary-oedema chapter.
The Bottom Line
- Acute pulmonary oedema is a medical emergency causing impaired gas exchange, severe breathlessness and hypoxia.
- Assess respiratory distress, oxygenation, blood pressure, perfusion, congestion and possible acute coronary, arrhythmic, infective or medicine-related precipitants.
- Obtain ECG and pathway-indicated blood tests and imaging without delaying stabilisation or retrieval.
- Oxygen, ventilatory support, vasodilator and diuretic decisions depend on physiology, current protocol and senior medical direction.
Practical clinical workflow
1
Record repeated observations and rapid history of heart disease, medicines, adherence, allergies and symptom onset.
2
Position, monitor and support airway and breathing within scope while contacting senior medical and retrieval services.
3
Treat the blood-pressure and congestion phenotype under the acute pathway and monitor response and kidney function.
4
After stabilisation, identify the precipitant and arrange national-guideline chronic heart-failure optimisation and early follow-up.
Safety boundaries and escalation
- Shock, severe hypoxia, respiratory fatigue, acute ischaemia or dangerous arrhythmia requires immediate emergency and critical-care escalation.
- Do not give unmonitored fluid or copy a vasoactive or diuretic regimen without assessing current blood pressure, congestion and senior direction.
Implementation
Queensland PCCM acute pulmonary oedema is a Queensland source. It supplies an Australian implementation example, not a national rule. Confirm the equivalent pathway, referral destination and medicine policy in the patient’s state or territory. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO–RACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
Clinical use boundary
This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- National Heart Foundation of Australia and Cardiac Society of Australia and New ZealandGuidelines for the prevention, detection and management of heart failure in Australia 2018DOI 10.1016/j.hlc.2018.06.1042 · 2018 guideline; current status checked 2026-08-20 · accessed 2026-08-20view source
- Queensland Health and Royal Flying Doctor Service Queensland SectionPrimary Clinical Care Manual, 12th edition: Acute pulmonary oedema (cardiac causes) — adultISBN 978-1-876560-22-5; Acute pulmonary oedema (cardiac causes) — adult, pp. 110–113 · 12th edition 2025, v1.03 with updates through 21 July 2026; exact chapter at printed pages 110–113 · accessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.